Clinical Trials Browser

Interventional × Lung Neoplasms × icotinib × Clear all

NCT07458919 2026-03-09

Therapy for Advanced NSCLC With EGFR 19delins Mutation

Phase EARLY_PHASE1 Not yet recruiting

Lung Neoplasms

NCT02264210 2024-09-25

CORIN

Phase 2 Completed

128 enrolled 9 charts

Adenocarcinoma of Lung, Bronchial Neoplasms, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT01996098 2024-09-05

ICTAN

Phase 3 Terminated

Lung Neoplasms

NCT02744664 2020-05-27

Cryotherapy Combine Icotinib for Advanced NSCLC Treatment

Phase 4 Completed

Lung Neoplasms

NCT02889692 2019-04-11

Clinical Study of Chinese Medicine Plus Targeted Therapy Maintenance in Advanced Pulmonary Adenocarcinoma

Phase 3 Completed

Lung Neoplasms, Neoplasms

NCT03151161 2018-06-07

Intermittent and Maintenance of Icotinib in Combination With Pemetrexed/Carboplatin Compared With Icotinib Single Drug in Ⅲb/IV Non Small Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR) Mutation

Phase 2 Unknown

Lung Neoplasms

NCT03153358 2017-05-16

Icotinib Combined With SBRT for Patients With Metastatic Non-squamous NSCLC With EGFR Mutation

Phase 2 Unknown

Lung Neoplasms

NCT02375022 2015-03-24

Rh-Endostatin in Combination With Icotinib for Advanced NSCLC With EGFR Mutations

Phase 2 Unknown

Lung Neoplasms

NCT01514877 2014-07-23

Icotinib Combined With Whole Brain Radiotherapy in Treating Multiple Brain Metastases From Non-Small Cell Lung Cancer

Phase 2 Completed

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasm Metastasis